1. Home
  2. EMBC vs INNV Comparison

EMBC vs INNV Comparison

Compare EMBC & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • INNV
  • Stock Information
  • Founded
  • EMBC 1924
  • INNV 2007
  • Country
  • EMBC United States
  • INNV United States
  • Employees
  • EMBC N/A
  • INNV N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • INNV Medical/Nursing Services
  • Sector
  • EMBC Health Care
  • INNV Health Care
  • Exchange
  • EMBC Nasdaq
  • INNV Nasdaq
  • Market Cap
  • EMBC 788.4M
  • INNV 485.4M
  • IPO Year
  • EMBC N/A
  • INNV 2021
  • Fundamental
  • Price
  • EMBC $15.17
  • INNV $5.07
  • Analyst Decision
  • EMBC Buy
  • INNV Sell
  • Analyst Count
  • EMBC 2
  • INNV 3
  • Target Price
  • EMBC $18.50
  • INNV $5.00
  • AVG Volume (30 Days)
  • EMBC 490.0K
  • INNV 37.3K
  • Earning Date
  • EMBC 08-08-2025
  • INNV 09-09-2025
  • Dividend Yield
  • EMBC 3.97%
  • INNV N/A
  • EPS Growth
  • EMBC 18.26
  • INNV N/A
  • EPS
  • EMBC 1.42
  • INNV N/A
  • Revenue
  • EMBC $1,102,500,000.00
  • INNV $853,699,000.00
  • Revenue This Year
  • EMBC N/A
  • INNV $10.46
  • Revenue Next Year
  • EMBC N/A
  • INNV $10.50
  • P/E Ratio
  • EMBC $10.63
  • INNV N/A
  • Revenue Growth
  • EMBC N/A
  • INNV 11.76
  • 52 Week Low
  • EMBC $9.20
  • INNV $2.60
  • 52 Week High
  • EMBC $21.48
  • INNV $6.69
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 65.84
  • INNV 69.92
  • Support Level
  • EMBC $14.92
  • INNV $3.69
  • Resistance Level
  • EMBC $15.55
  • INNV $5.31
  • Average True Range (ATR)
  • EMBC 0.52
  • INNV 0.36
  • MACD
  • EMBC -0.09
  • INNV 0.13
  • Stochastic Oscillator
  • EMBC 74.15
  • INNV 86.72

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About INNV InnovAge Holding Corp.

InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.

Share on Social Networks: